Global Prostate-Specific Antigen (PSA) Test Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Prostate-Specific Antigen (PSA) Test Revenue
• 1.4 Market by Type
  • 1.4.1 Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 CLIA
  • 1.4.3 ELISA
  • 1.4.4 Other
• 1.5 Market by Application
  • 1.5.1 Global Prostate-Specific Antigen (PSA) Test Market Share by Application: 2020 VS 2026
  • 1.5.2 Screening
  • 1.5.3 Post-treatment Monitoring
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Prostate-Specific Antigen (PSA) Test Market Perspective (2015-2026)
• 2.2 Global Prostate-Specific Antigen (PSA) Test Growth Trends by Regions
  • 2.2.1 Prostate-Specific Antigen (PSA) Test Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Prostate-Specific Antigen (PSA) Test Historic Market Share by Regions (2015-2020)
  • 2.2.3 Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Prostate-Specific Antigen (PSA) Test Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Prostate-Specific Antigen (PSA) Test Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Market Size
  • 3.1.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue (2015-2020)
  • 3.1.2 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio
  • 3.2.1 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Prostate-Specific Antigen (PSA) Test Revenue in 2019
• 3.3 Prostate-Specific Antigen (PSA) Test Key Players Head office and Area Served
• 3.4 Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
• 3.5 Date of Enter into Prostate-Specific Antigen (PSA) Test Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Type (2015-2020)
• 4.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)
• 5.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
• 6.2 Prostate-Specific Antigen (PSA) Test Key Players in North America (2019-2020)
• 6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
• 6.4 North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
• 7.2 Prostate-Specific Antigen (PSA) Test Key Players in Europe (2019-2020)
• 7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
• 7.4 Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

8 China

• 8.1 China Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
• 8.2 Prostate-Specific Antigen (PSA) Test Key Players in China (2019-2020)
• 8.3 China Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
• 8.4 China Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
• 9.2 Prostate-Specific Antigen (PSA) Test Key Players in Japan (2019-2020)
• 9.3 Japan Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
• 9.4 Japan Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
• 10.2 Prostate-Specific Antigen (PSA) Test Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
• 10.4 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

11 India

• 11.1 India Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
• 11.2 Prostate-Specific Antigen (PSA) Test Key Players in India (2019-2020)
• 11.3 India Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
• 11.4 India Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
• 12.2 Prostate-Specific Antigen (PSA) Test Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
• 12.4 Central & South America Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview
  • 13.1.3 Abbott Prostate-Specific Antigen (PSA) Test Introduction
  • 13.1.4 Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 Siemens Healthcare
  • 13.2.1 Siemens Healthcare Company Details
  • 13.2.2 Siemens Healthcare Business Overview
  • 13.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Introduction
  • 13.2.4 Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  • 13.2.5 Siemens Healthcare Recent Development
• 13.3 DiaSorin
  • 13.3.1 DiaSorin Company Details
  • 13.3.2 DiaSorin Business Overview
  • 13.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Introduction
  • 13.3.4 DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  • 13.3.5 DiaSorin Recent Development
• 13.4 Roche
  • 13.4.1 Roche Company Details
  • 13.4.2 Roche Business Overview
  • 13.4.3 Roche Prostate-Specific Antigen (PSA) Test Introduction
  • 13.4.4 Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  • 13.4.5 Roche Recent Development
• 13.5 Beckman Coulter
  • 13.5.1 Beckman Coulter Company Details
  • 13.5.2 Beckman Coulter Business Overview
  • 13.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Introduction
  • 13.5.4 Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  • 13.5.5 Beckman Coulter Recent Development
• 13.6 PerkinElmer
  • 13.6.1 PerkinElmer Company Details
  • 13.6.2 PerkinElmer Business Overview
  • 13.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Introduction
  • 13.6.4 PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  • 13.6.5 PerkinElmer Recent Development
• 13.7 Tosoh
  • 13.7.1 Tosoh Company Details
  • 13.7.2 Tosoh Business Overview
  • 13.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Introduction
  • 13.7.4 Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  • 13.7.5 Tosoh Recent Development
• 13.8 Ortho Clinical
  • 13.8.1 Ortho Clinical Company Details
  • 13.8.2 Ortho Clinical Business Overview
  • 13.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Introduction
  • 13.8.4 Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  • 13.8.5 Ortho Clinical Recent Development
• 13.9 Fujirebio
  • 13.9.1 Fujirebio Company Details
  • 13.9.2 Fujirebio Business Overview
  • 13.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Introduction
  • 13.9.4 Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  • 13.9.5 Fujirebio Recent Development
• 13.10 Mediwatch (LABORIE)
  • 13.10.1 Mediwatch (LABORIE) Company Details
  • 13.10.2 Mediwatch (LABORIE) Business Overview
  • 13.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Introduction
  • 13.10.4 Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  • 13.10.5 Mediwatch (LABORIE) Recent Development
• 13.11 BodiTech
  • 10.11.1 BodiTech Company Details
  • 10.11.2 BodiTech Business Overview
  • 10.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Introduction
  • 10.11.4 BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
  • 10.11.5 BodiTech Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer